Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R C Seeger

Showing results (101-110 of 155) with videos related to

Pageof 16
Sort By:
Cancer Research|June 1, 1985
Prognostic importance of serum ferritin in patients with Stages III and IV neuroblastoma: the Childrens Cancer Study Group experienceH W Hann, A E Evans, S E Siegel, et al.
Journal of Pediatric Hematology/Oncology|August 26, 2000
Antineuronal antibodies in patients with neuroblastoma and paraneoplastic opsoclonus-myoclonusN L Antunes, Y Khakoo, K K Matthay, et al.
Lancet (London, England)|August 13, 1983
Raised neuron-specific enolase in serum of children with metastatic neuroblastoma. A report from the Children's Cancer Study GroupP M Zeltzer, P J Marangos, A M Parma, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1995
Phase I trial of 13-cis-retinoic acid in children with neuroblastoma following bone marrow transplantationJ G Villablanca, A A Khan, V I Avramis, et al.
Journal of Pediatric Surgery|September 1, 1991
Aggressive surgery combined with intensive chemotherapy improves survival in poor-risk neuroblastomaG M Haase, M C O'Leary, N K Ramsay, et al.
Cancer Research|February 24, 2001
Homozygous deletion of CDKN2A (p16INK4a/p14ARF) but not within 1p36 or at other tumor suppressor loci in neuroblastomaP M Thompson, J M Maris, M D Hogarty, et al.
Cancer Treatment Reports|January 1, 1980
Variability in DNA distributions of human neuroblastomas after cyclophosphamideY L Danon, M B Epstein, M M Siegel, et al.
Medical and Pediatric Oncology|December 7, 2000
Multidrug resistance-associated protein 1 (MRP1) expression in neuroblastoma cell lines and primary tumorsH Goto, N Keshelava, K K Matthay, et al.
Oncogene|April 1, 1992
Cell type-specific expression and negative regulation by retinoic acid of the human N-myc promoter in neuroblastoma cellsR K Wada, R C Seeger, C P Reynolds, et al.
British Journal of Cancer|April 30, 2009
Consensus criteria for sensitive detection of minimal neuroblastoma cells in bone marrow, blood and stem cell preparations by immunocytology and QRT-PCR: recommendations by the International Neuroblastoma Risk Group Task ForceK Beiske, S A Burchill, I Y Cheung, et al.
Pageof 16

Showing results (101-110 of 155) with videos related to

Sort By:
Pageof 16
Cancer Research|June 1, 1985
Prognostic importance of serum ferritin in patients with Stages III and IV neuroblastoma: the Childrens Cancer Study Group experienceH W Hann, A E Evans, S E Siegel, et al.
Journal of Pediatric Hematology/Oncology|August 26, 2000
Antineuronal antibodies in patients with neuroblastoma and paraneoplastic opsoclonus-myoclonusN L Antunes, Y Khakoo, K K Matthay, et al.
Lancet (London, England)|August 13, 1983
Raised neuron-specific enolase in serum of children with metastatic neuroblastoma. A report from the Children's Cancer Study GroupP M Zeltzer, P J Marangos, A M Parma, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1995
Phase I trial of 13-cis-retinoic acid in children with neuroblastoma following bone marrow transplantationJ G Villablanca, A A Khan, V I Avramis, et al.
Journal of Pediatric Surgery|September 1, 1991
Aggressive surgery combined with intensive chemotherapy improves survival in poor-risk neuroblastomaG M Haase, M C O'Leary, N K Ramsay, et al.
Cancer Research|February 24, 2001
Homozygous deletion of CDKN2A (p16INK4a/p14ARF) but not within 1p36 or at other tumor suppressor loci in neuroblastomaP M Thompson, J M Maris, M D Hogarty, et al.
Cancer Treatment Reports|January 1, 1980
Variability in DNA distributions of human neuroblastomas after cyclophosphamideY L Danon, M B Epstein, M M Siegel, et al.
Medical and Pediatric Oncology|December 7, 2000
Multidrug resistance-associated protein 1 (MRP1) expression in neuroblastoma cell lines and primary tumorsH Goto, N Keshelava, K K Matthay, et al.
Oncogene|April 1, 1992
Cell type-specific expression and negative regulation by retinoic acid of the human N-myc promoter in neuroblastoma cellsR K Wada, R C Seeger, C P Reynolds, et al.
British Journal of Cancer|April 30, 2009
Consensus criteria for sensitive detection of minimal neuroblastoma cells in bone marrow, blood and stem cell preparations by immunocytology and QRT-PCR: recommendations by the International Neuroblastoma Risk Group Task ForceK Beiske, S A Burchill, I Y Cheung, et al.
Pageof 16